TABLE IV -. Bio-Z and bnp changes in 16 RANCHF patients with initially abnormal P&S results.
(M ± SD) | Hemodynamically improved (n = 9) | Hemodynamically unchanged (n = 7) | ||||
---|---|---|---|---|---|---|
preRAN | 12 months | p | preRAN | 12 months | p | |
BNP = brain natriuretic peptide; CI = cardiac index (l/in/m2, mean); RANCHF = Congestive Heart Failure patients prescribed RANolazine; SI = stroke index (l/in/m2, mean), see Table II for more abbreviations. | ||||||
CI | 2.14 ± 0.59 | 3.14 ± 0.61 | 0.004 | 2.44 ± 0.89 | 2.40 ± 0.74 | 1.000 |
SI | 0.30 ± 0.10 | 0.46 ± 0.11 | 0.004 | 0.32 ± 0.15 | 0.31 ± 0.13 | 0.730 |
BNP | 481 ± 316 | 73 ± 37 | 0.039 | 293 ± 254 | 218 ± 172 | 0.730 |